Related Experiment Videos
Adverse cardiovascular effects of NSAIDs in patients with congestive heart failure
J Feenstra1, D E Grobbee, A Mosterd
1Department of Epidemiology and Biostatistics, Erasmus University Medical School Rotterdam, The Netherlands.
Insights
Nonsteroidal anti-inflammatory drugs (NSAIDs) may increase the risk of congestive heart failure (CHF) in elderly patients. Further research is needed to quantify this risk and identify susceptible individuals.
Area of Science:
- Cardiology
- Pharmacology
- Geriatrics
Background:
- Congestive heart failure (CHF) is a growing concern, particularly in the elderly population.
- NSAIDs are commonly prescribed for elderly patients, presenting potential risks.
- Existing evidence suggests a possible link between NSAID use and the onset of CHF.
Purpose of the Study:
- To investigate the potential causal relationship between NSAID use and congestive heart failure.
- To understand the pathophysiological mechanisms linking NSAIDs to CHF.
- To identify elderly patients at higher risk for NSAID-induced cardiovascular adverse effects.
Main Methods:
- Review of epidemiological data on CHF prevalence and hospitalization rates.
- Analysis of NSAID pharmacological properties and their impact on cardiovascular homeostasis.
- Examination of case reports suggesting a link between NSAIDs and CHF onset.
Main Results:
- NSAID use, particularly through prostaglandin synthesis inhibition, may negatively impact cardiovascular stability.
- Elderly patients with a predisposition to CHF may be more susceptible to adverse cardiovascular effects from NSAIDs.
- While NSAIDs are often necessary for elderly patients, their cardiovascular risks require careful consideration.
Conclusions:
- NSAIDs may pose a risk for developing or exacerbating congestive heart failure in the elderly.
- Further pharmaco-epidemiological studies are crucial to quantify the risk and identify vulnerable patient groups.
- Avoiding NSAIDs in susceptible elderly individuals may be advisable to mitigate cardiovascular risks.
Abstract:
Congestive heart failure (CHF) is a complex clinical syndrome, especially in the elderly, which results from cardiac dysfunction. Epidemiological studies have shown a gradual increase in age-adjusted hospitalisation rates for CHF and overall population prevalence of CHF during the last 2 decades in Western countries. The healthcare costs associated with CHF are considerable and are likely to increase in the near future. Hence, identification of risk factors which could induce or exacerbate CHF is of major importance. NSAIDs are frequently prescribed in elderly patients for several rheumatological and nonrheumatological indications. Numerous adverse reactions, mainly related to the gastrointestinal tract and kidney function, have been described for NSAIDs. In addition, some case reports have suggested a causal relation between the use of NSAIDs and the onset of CHF. The pathophysiology of CHF and the pharmacological properties of NSAIDs support this hypothesis. In particular, the inhibition of prostaglandin synthesis may adversely affect cardiovascular homeostasis in patients with a propensity to develop CHF. Notwithstanding the adverse effects, however, the prescription of NSAIDs in elderly patients is often desirable and justifiable. Therefore, further pharmaco-epidemiological research is needed to quantify the risk for CHF attributable to the use of NSAIDs and to identify patients who are particularly susceptible to the adverse cardiovascular effects of these agents. In these patients, it may be advisable to avoid the use of NSAIDs.